ClinicalTrials.Veeva

Menu

Risk Stratification in Severe Treatment-naive, Tricuspid Regurgitation (TRuE)

Charité University Medicine Berlin logo

Charité University Medicine Berlin

Status

Unknown

Conditions

Functional Tricuspid Regurgitation

Treatments

Diagnostic Test: No Intervention

Study type

Observational

Funder types

Other

Identifiers

NCT04173091
TRuE012013

Details and patient eligibility

About

This registry is aimed to characterize patients with severe tricuspid regurgitation for the purpose of patient selection for interventional treatment and identify factors related to adverse outcomes.

Enrollment

2,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Severe functional tricuspid regurgitation

Exclusion criteria

prior surgery or congenital heart diseases with involvement of the tricuspid valve

Trial contacts and locations

5

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems